JP2007527417A5 - - Google Patents

Download PDF

Info

Publication number
JP2007527417A5
JP2007527417A5 JP2006541459A JP2006541459A JP2007527417A5 JP 2007527417 A5 JP2007527417 A5 JP 2007527417A5 JP 2006541459 A JP2006541459 A JP 2006541459A JP 2006541459 A JP2006541459 A JP 2006541459A JP 2007527417 A5 JP2007527417 A5 JP 2007527417A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
pharmaceutical formulation
administered
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541459A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007527417A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039716 external-priority patent/WO2005055926A2/en
Publication of JP2007527417A publication Critical patent/JP2007527417A/ja
Publication of JP2007527417A5 publication Critical patent/JP2007527417A5/ja
Pending legal-status Critical Current

Links

JP2006541459A 2003-11-20 2004-11-22 白内障、黄斑変性および他の眼疾患の改善 Pending JP2007527417A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52380303P 2003-11-20 2003-11-20
PCT/US2004/039716 WO2005055926A2 (en) 2003-11-20 2004-11-22 Amelioration of cataracts, macular degeneration and other ophthalmic diseases

Publications (2)

Publication Number Publication Date
JP2007527417A JP2007527417A (ja) 2007-09-27
JP2007527417A5 true JP2007527417A5 (https=) 2008-01-17

Family

ID=34676585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541459A Pending JP2007527417A (ja) 2003-11-20 2004-11-22 白内障、黄斑変性および他の眼疾患の改善

Country Status (8)

Country Link
EP (1) EP1689354A4 (https=)
JP (1) JP2007527417A (https=)
KR (1) KR20070040326A (https=)
CN (1) CN101102770A (https=)
AU (1) AU2004296738A1 (https=)
CA (1) CA2546053A1 (https=)
IL (1) IL175498A0 (https=)
WO (1) WO2005055926A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589107B2 (en) 2003-05-19 2009-09-15 Othera Holding, Inc. Amelioration of vitrectomy-induced cataracts
US20080312283A1 (en) * 2005-05-26 2008-12-18 Othera Pharmaceuticals, Inc. Use of Hydroxylamine Derivates for Inhibiting Vitrectomy-Induced Cataracts
CA2640738A1 (en) * 2006-02-22 2007-09-07 Othera Holding, Inc. Hydroxylamines and derivatives for the inhibition of complement activation
CA2678363A1 (en) * 2007-02-16 2008-08-21 Othera Holding, Inc. Drug resistance reversal in neoplastic disease
BRPI0807571A2 (pt) * 2007-02-22 2014-07-01 Othera Holding Inc Compostos de hidroxilamina e métodos de seu uso
EP2217589A4 (en) * 2007-11-28 2012-02-22 Revision Therapeutics Inc MODULATORS OF OCULAR OXIDATIVE STRESS
EP2080513A1 (en) * 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
CN102988331B (zh) * 2012-05-31 2015-02-04 管孝君 2-巯基-3-丁醇用于制备抗晶状体混浊产品的用途
CA2946422C (en) * 2014-04-30 2019-03-05 The Johns Hopkins University Dendrimer compositions and their use in treatment of diseases of the eye
JP6342575B2 (ja) 2014-08-13 2018-06-13 ザ・ジョンズ・ホプキンス・ユニバーシティー 脳腫瘍への選択的デンドリマー送達
US20170246176A1 (en) * 2014-10-31 2017-08-31 Keio University Phacosclerosis inhibitor
IL270169B2 (en) 2017-04-27 2024-08-01 Univ Johns Hopkins Dendrimer preparations for use in angiography
WO2018201124A1 (en) * 2017-04-28 2018-11-01 Case Western Reserve University Antioxidants for use in ophthalmic surgery
US11918657B2 (en) 2017-11-10 2024-03-05 The Johns Hopkins University Dendrimer delivery system and methods of use thereof
JP7759322B2 (ja) 2019-12-04 2025-10-23 アシュバッタ セラピューティクス, インコーポレイテッド 眼に薬物送達するためのデンドリマー組成物および方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
DE68917946T2 (de) * 1988-01-29 1995-01-05 Peter H Proctor Haarwachstumanregung mit Nitroxyd und anderen Radikalen.
WO1995017900A1 (en) * 1993-12-30 1995-07-06 Arcturus Pharmaceutical Corporation Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways
DE69425287T2 (de) * 1994-11-15 2001-03-15 Moreno Paolini N-hydroxypiperidine als superoxid-radikalfänger
US6001853A (en) * 1996-01-26 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Hydroxylamine compositions for the prevention or retardation of cataracts
US20030109566A1 (en) * 2000-06-29 2003-06-12 Tomiya Mano Remedial agent for optic nerve disease and the like
IT1320080B1 (it) * 2000-10-25 2003-11-18 Giuliani Spa Composizione per uso farmaceutico o dietetico.
KR20060013632A (ko) * 2002-05-17 2006-02-13 오쎄라 파마슈티걸즈, 인크. 백내장 및 다른 안질환 발병의 개선

Similar Documents

Publication Publication Date Title
Casson Medical therapy for glaucoma: A review
JP2007527417A5 (https=)
RU2470635C2 (ru) Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза
JP2008531714A (ja) 不安障害の治療用及び/又は予防用の医薬組成物
JP2011510014A5 (https=)
JP2006524185A5 (https=)
WO2011053792A4 (en) Methods and compositions for sustained delivery of drugs
JP2008538741A (ja) 鬱病の治療用及び/又は予防用の医薬組成物
EA201000441A1 (ru) Водные офтальмологические препараты
ES2540151B1 (es) Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
JP2005527605A5 (https=)
JP2021506971A (ja) イソキサゾリン系寄生虫駆除剤及び眼瞼炎を治療する方法
JP2017520527A5 (https=)
BRPI1016257B1 (pt) composições compreendendo finafloxacina para tratamento de infecções óticas
RU2431502C2 (ru) Фармацевтические композиции для лечения сухости глаз
CN115768419A (zh) 用于色满卡林前药治疗的改进方法和组合物
ES2604816A1 (es) Composición farmacéutica de tramadol para uso oftálmico
AU2017261303A1 (en) Ophthalmic compositions
JP2024041947A (ja) 眼圧下降増強剤
FI2765988T3 (fi) Silmäkoostumus, joka sisältää bromfenaakkia, jolla on parannettu biologinen hyötyosuus
JP2009538827A (ja) カンナビノイドおよび使用方法
Petrov et al. Modern methods of minimally invasive glaucoma surgery
RU2020119228A (ru) Соединения, композиции и способы лечения нарушений со стороны органа зрения и заболеваний кожи
JP2016518312A (ja) 眼科炎症疾患治療用点眼剤組成物及びその製造方法
JP2023506838A5 (https=)